Abstract
A highly hydrophobic alkylating agent, 1-N,N-bis(beta-bromoethyl) amino-3-methylnaphthalene, given as the free drug in oil, cured a substantial proportion of mice bearing the PC6 myeloma in the dose range 2-7 mg/kg. However, these doses were toxic, and the LD50 was 6-7 mg/kg. When incorporated in liposomes, similar curative effects were obtained at doses of 10-41 mg/kg without material toxicity, even at the highest dose. Liposome entrapment therefore greatly increases the therapeutic efficiency of this agent.
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Babbage, J., Berenbaum, M. Increased therapeutic efficiency of a lipid-soluble alkylating agent incorporated in liposomes. Br J Cancer 45, 830–834 (1982). https://doi.org/10.1038/bjc.1982.134
Issue Date:
DOI: https://doi.org/10.1038/bjc.1982.134
- Springer Nature Limited